What is Pathways Bioscience?
Pathways Bioscience is dedicated to enhancing lifespan and combating age-related challenges through innovative agents that optimize cellular defense pathways. Their flagship product, PB125, is a dietary supplement formulated with natural ingredients such as rosemary, ashwagandha, and luteolin. This supplement is designed to activate the Nrf2 pathway, thereby supporting health and vitality in health-conscious individuals seeking to manage aging-related issues. The company emphasizes scientific credibility and integrity in its mission to provide trustworthy solutions for a healthier, longer life.
How much funding has Pathways Bioscience raised?
Pathways Bioscience has raised a total of $19K across 1 funding round:
Debt
$19K
Debt (2021): $19K with participation from PPP
What's next for Pathways Bioscience?
With its Series A/B growth stage funding context, Pathways Bioscience is poised for significant scaling and market expansion. The recent investment, amounting to $19K, will likely be directed towards advancing product development, broadening clinical research, and enhancing market penetration for PB125. The company's focus on the Nrf2 pathway and natural ingredients aligns with growing consumer interest in preventative health and longevity solutions. Future strategic moves may involve further product line diversification and strategic partnerships to solidify its position in the burgeoning longevity market.
See full Pathways Bioscience company page
